The history of the Gilead developed antiviral Remdesivir | Mark Kulacz

7 March 2023 | For anyone involved in researching the Covid-19 pandemic origin and response, and to improve policies, this presentation by Mark Kulacz reviews available evidence on Remdesivir and will fill in your knowledge gaps on this critical topic.

“We still have questions regarding the roll out of Remdesivir - it was perhaps every bit as important as any vaccine that has been trialed or used”.

Mark Kulacz was the lead competitive intelligence analyst for Dell's data storage division, before starting the research channel Housatonic.Live https://sites.google.com/housatonicits.com/live/home

PANDA’s weekly Open Science Sessions provide an opportunity for science, research and policy to be presented by various leading international experts in a variety of diverse fields. These sessions aim to broaden understanding and inspire new insights.

See more of our Open Science Sessions here: www.pandata.org/open-science-sessions/
Support our work: www.pandata.org/donate/